Sanjay Subramanian

(Mr. Sanjay Subramanian)

Currently holds a position at Ocugen Inc

Positions

Position Company Period
Chief Financial Officer Ocugen Inc Oct. 1, 2019 -
Sanjay Subramanian's trades of Inozyme Pharma Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-04-20 2022-04-19
B Purchase
27,100 +inf%
3.69
USD 99,999 		27,100 +inf% 3.69 USD 99,999
2021-10-27 2021-10-26
US Ocugen Inc (OCGN)
PS Planned sale
10,000 -21.9%
11.07
USD 110,700 		10,000 -21.9% 11.07 USD 110,700
2021-10-15 2021-10-15
US Ocugen Inc (OCGN)
PS Planned sale
7,990 -14.9%
9.96
USD 79,580 		7,990 -14.9% 9.96 USD 79,580
2021-06-17 2021-06-15
US Ocugen Inc (OCGN)
PS Planned sale
31,000 -40.5%
7.00
USD 217,000 		31,000 -40.5% 7.00 USD 217,000
2021-05-03 2021-04-29
US Ocugen Inc (OCGN)
PS Planned sale
7,990 -14.9%
10.98
USD 87,730 		7,990 -14.9% 10.98 USD 87,730
2019-10-04 2019-10-02
US Ocugen Inc (OCGN)
B Purchase
5,000 +inf%
1.88
USD 9,400 		5,000 +inf% 1.88 USD 9,400
// ... existing code ... // ... rest of the file ...